275 related articles for article (PubMed ID: 12214272)
1. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation.
Karimpour S; Lou J; Lin LL; Rene LM; Lagunas L; Ma X; Karra S; Bradbury CM; Markovina S; Goswami PC; Spitz DR; Hirota K; Kalvakolanu DV; Yodoi J; Gius D
Oncogene; 2002 Sep; 21(41):6317-27. PubMed ID: 12214272
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation.
Wei SJ; Botero A; Hirota K; Bradbury CM; Markovina S; Laszlo A; Spitz DR; Goswami PC; Yodoi J; Gius D
Cancer Res; 2000 Dec; 60(23):6688-95. PubMed ID: 11118054
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
[TBL] [Abstract][Full Text] [Related]
4. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity.
Seemann S; Hainaut P
Oncogene; 2005 Jun; 24(24):3853-63. PubMed ID: 15824742
[TBL] [Abstract][Full Text] [Related]
5. Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.
Hu J; Ma X; Lindner DJ; Karra S; Hofmann ER; Reddy SP; Kalvakolanu DV
Oncogene; 2001 Jul; 20(31):4235-48. PubMed ID: 11464290
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin reductase as a novel molecular target for cancer therapy.
Nguyen P; Awwad RT; Smart DD; Spitz DR; Gius D
Cancer Lett; 2006 May; 236(2):164-74. PubMed ID: 15955621
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium.
Gallegos A; Berggren M; Gasdaska JR; Powis G
Cancer Res; 1997 Nov; 57(21):4965-70. PubMed ID: 9354464
[TBL] [Abstract][Full Text] [Related]
8. Redox regulation of SH2-domain-containing protein tyrosine phosphatases by two backdoor cysteines.
Chen CY; Willard D; Rudolph J
Biochemistry; 2009 Feb; 48(6):1399-409. PubMed ID: 19166311
[TBL] [Abstract][Full Text] [Related]
9. Direct association of hepatopoietin with thioredoxin constitutes a redox signal transduction in activation of AP-1/NF-kappaB.
Li Y; Liu W; Xing G; Tian C; Zhu Y; He F
Cell Signal; 2005 Aug; 17(8):985-96. PubMed ID: 15894171
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
Sakurai A; Nishimoto M; Himeno S; Imura N; Tsujimoto M; Kunimoto M; Hara S
J Cell Physiol; 2005 Jun; 203(3):529-37. PubMed ID: 15521073
[TBL] [Abstract][Full Text] [Related]
11. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
Lincoln DT; Ali Emadi EM; Tonissen KF; Clarke FM
Anticancer Res; 2003; 23(3B):2425-33. PubMed ID: 12894524
[TBL] [Abstract][Full Text] [Related]
12. Heat shock and the activation of AP-1 and inhibition of NF-kappa B DNA-binding activity: possible role of intracellular redox status.
Mattson D; Bradbury CM; Bisht KS; Curry HA; Spitz DR; Gius D
Int J Hyperthermia; 2004 Mar; 20(2):224-33. PubMed ID: 15195516
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress.
Smart DK; Ortiz KL; Mattson D; Bradbury CM; Bisht KS; Sieck LK; Brechbiel MW; Gius D
Cancer Res; 2004 Sep; 64(18):6716-24. PubMed ID: 15374989
[TBL] [Abstract][Full Text] [Related]
15. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1.
Hansen JM; Watson WH; Jones DP
Toxicol Sci; 2004 Nov; 82(1):308-17. PubMed ID: 15282410
[TBL] [Abstract][Full Text] [Related]
16. Impairment of thioredoxin reductase activity by oxidative stress in human rheumatoid synoviocytes.
Lemarechal H; Anract P; Beaudeux JL; Bonnefont-Rousselot D; Ekindjian OG; Borderie D
Free Radic Res; 2007 Jun; 41(6):688-98. PubMed ID: 17516242
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.
Tonissen KF; Di Trapani G
Mol Nutr Food Res; 2009 Jan; 53(1):87-103. PubMed ID: 18979503
[TBL] [Abstract][Full Text] [Related]
18. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
[TBL] [Abstract][Full Text] [Related]
19. Induction of thioltransferase and thioredoxin/thioredoxin reductase systems in cultured porcine lenses under oxidative stress.
Moon S; Fernando MR; Lou MF
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3783-9. PubMed ID: 16186363
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
Söderberg A; Sahaf B; Rosén A
Cancer Res; 2000 Apr; 60(8):2281-9. PubMed ID: 10786696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
